Under an exclusive licence option agreement, Heidelberg Pharma will develop ATACs (alpha-amanitin antibody...
Up To Date
Latest News
Investments into new drugs to tackle antimicrobial resistance (AMR) are set to boost the participation of...
Swiss Santhera Pharmaceuticals EU-approved LHON treatment Raxone (idebenone) has failed to show clinical...
An US-German team has found a way to halt the inflammatory brain cell destruction in mice with multiple...
Liège-based Convert Pharmaceuticals SA has been granted a total of €13.6m in equity and non-dilutive funding...
Novo Holdings has launched the REPAIR impact fund commissioned by the Novo Nordisk Foundation. The goal is to...